SAKK & Celgene’s “Life Grant” for Research on Pancreatic Cancer Care 2018
Pancreatic cancer remains a devastating disease associated with a poor survival prognosis and a significant impairment of the quality of life of patients and their relatives. SAKK and Celgene share a common interest in innovative research for life-changing medication and therapeutic concepts for patients with high unmet medical needs.
The Life Grant supports planned or ongoing research projects in pancreatic cancer care aiming to improve the quality of life of patients and their relatives.
Key Information about the Grant:
An independent jury, chaired by the SAKK president Prof. Roger von Moos, evaluates all projects and announces the grant winner at the semi-annual SAKK meeting in November 2018, where he/she will be requested to present a short exposé on the planned research. Further notifications about the winning project will be published in the Schweizer Krebsbulletin, the SAKK newsletter and on this website.
For the full requirements and more information on the eligibility of the projects, please read the Rules & Regulations.
We are looking forward to read about your innovative project soon.